Mastercard vs Pfizer: Founders, CEOs and History
Mastercard was founded in 1966 by Karl Hinke and is led by Michael Miebach. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Mastercard
- Founded
- 1966
- Headquarters
- Purchase, New York, United States
- Current CEO
- Michael Miebach
- Employees
- 39,800
Pfizer
- Founded
- 1849
- Headquarters
- New York, New York
- Current CEO
- Albert Bourla
- Employees
- 75,000
Founders
Mastercard
Karl Hinke
Karl Hinke was an executive at Marine Midland Bank in New York who helped organize the Interbank Card Association in 1966.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
Mastercard
- Robert W. Selander1997–2010
President and CEO
Selander turned a bank-owned association into an independent public company, completing the 2002 Europay merger and the 2006 NYSE IPO.
Source - Ajay Banga2010–2020
CEO
Banga oversaw a decade of rapid growth, pushed tokenization and digital wallets, and bought Vocalink to enter real-time account-to-account payments. He later became President of the World Bank in 2023.
Source - Michael Miebach2021–present
CEO
Miebach has expanded value-added services to about 41% of net revenue and added Recorded Future and BVNK, extending Mastercard into threat intelligence and stablecoin infrastructure.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: Mastercard and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1966Mastercard
Interbank Card Association Takes Shape
A group of U.S. Banks formed the Interbank Card Association to make card acceptance work across institutions rather than inside isolated bank programs.
1968Mastercard
Master Charge Brand Adopted
The association adopted the Master Charge name and interlocking-circle design to give member banks a stronger shared identity. A common brand made the network easier for merchants and consumers to recognize as acceptance expanded beyond local bank programs.
1979Mastercard
Master Charge Becomes MasterCard
The network changed its name from Master Charge to MasterCard as it became more international. The rebrand simplified recognition and helped the company present itself as a global acceptance network rather than a domestic bank-card association.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2002Mastercard
Europay Merger and Corporate Conversion
MasterCard merged with Europay International and converted from a membership association into a private share corporation. That structure prepared the company for public-market ownership and a more independent investment agenda.
2006Mastercard
Initial Public Offering on the NYSE
MasterCard priced its initial public offering at $39 per share and listed on the New York Stock Exchange under the symbol MA.
2017Mastercard
Vocalink Expands Real-Time Payments
Mastercard completed its Vocalink acquisition after announcing a deal for 92.4 percent of the U.K. Payments infrastructure company for about $920 million.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Mastercard
Finicity Strengthens Open Banking
Mastercard completed the acquisition of Finicity, a North American financial data and open banking platform. The deal added consumer-permissioned data connectivity for lending, account verification, personal finance, and account-based payment use cases.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2021Mastercard
Michael Miebach Becomes CEO
Michael Miebach became chief executive officer on January 1, 2021 after serving as chief product officer and president.
2021Mastercard
Nets Account-to-Account Business Closes
Mastercard completed the acquisition of the majority of Nets' Corporate Services business, adding clearing and settlement instant payment infrastructure, bill payment, and e-invoicing capabilities.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2024Mastercard
Recorded Future Adds Threat Intelligence
Mastercard completed the acquisition of Recorded Future, adding AI-enabled threat intelligence to its cybersecurity, identity, and real-time fraud scoring services.
2025Mastercard
$32.8B FY2025 Net Revenue
Mastercard reported $32.791 billion in FY2025 net revenue and $14.968 billion in net income.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Mastercard
BVNK Adds Stablecoin Infrastructure
Mastercard closed its acquisition of stablecoin infrastructure firm BVNK on August 3, 2026, for up to $1.8 billion including contingent payments. The deal extends the company's network to on-chain payments alongside cards and bank transfers.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
Mastercard
- BVNK2026$1.8B
- Recorded Future2024$2.6B
- Dynamic Yield2022Undisclosed
- Nets account-to-account payment business2021$3.2B
- Ekata2021$850M
- Aiia2021Undisclosed
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about Mastercard vs Pfizer
Who is the CEO of Mastercard Incorporated and Pfizer Inc.?
Mastercard Incorporated is led by Michael Miebach and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Mastercard Incorporated founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 117 years before Mastercard Incorporated, which was founded in 1966. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Mastercard Incorporated.
How many employees does Mastercard Incorporated have compared to Pfizer Inc.?
Mastercard Incorporated employs approximately 39,800 people, while Pfizer Inc. employs approximately 75,000. Pfizer Inc. has the larger workforce at 75,000 employees, compared to Mastercard Incorporated's 39,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Mastercard Incorporated and Pfizer Inc. headquartered?
Both Mastercard Incorporated and Pfizer Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Mastercard Incorporated and Pfizer Inc.?
Mastercard Incorporated was founded by Karl Hinke. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — Mastercard Incorporated or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Mastercard Incorporated has been in operation for around 60 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Mastercard vs Pfizer overview